STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$63,000
-6.0%
21,9250.0%0.00%
Q4 2021$67,000
-56.5%
21,9250.0%0.00%
Q3 2021$154,000
-23.4%
21,9250.0%0.00%
Q2 2021$201,000
-2.4%
21,925
+3.3%
0.00%
Q1 2021$206,000
-5.5%
21,2210.0%0.00%
Q4 2020$218,000
+1.9%
21,2210.0%0.00%
Q3 2020$214,000
-3.2%
21,2210.0%0.00%
-100.0%
Q2 2020$221,000
+23.5%
21,2210.0%0.00%0.0%
Q1 2020$179,000
-3.8%
21,2210.0%0.00%
Q4 2019$186,000
-18.4%
21,2210.0%0.00%
-100.0%
Q3 2019$228,000
+0.4%
21,221
+18.6%
0.00%0.0%
Q2 2019$227,000
-65.8%
17,888
+4.6%
0.00%
-50.0%
Q1 2019$664,000
+90.8%
17,1080.0%0.00%
+100.0%
Q4 2018$348,000
-55.6%
17,1080.0%0.00%
-50.0%
Q3 2018$784,000
-22.5%
17,1080.0%0.00%
-33.3%
Q2 2018$1,012,000
-8.3%
17,108
+5.4%
0.00%0.0%
Q1 2018$1,104,000
-33.7%
16,228
-3.7%
0.00%
-25.0%
Q4 2017$1,666,000
-13.9%
16,853
+4.3%
0.00%
-20.0%
Q3 2017$1,934,000
+37.0%
16,1530.0%0.01%
+25.0%
Q2 2017$1,412,000
+134.9%
16,1530.0%0.00%
+100.0%
Q1 2017$601,000
+21.2%
16,1530.0%0.00%
+100.0%
Q4 2016$496,000
-56.1%
16,153
-4.1%
0.00%
-75.0%
Q3 2016$1,129,000
+121.4%
16,843
-1.6%
0.00%
+100.0%
Q2 2016$510,000
-33.0%
17,123
-33.9%
0.00%
-33.3%
Q1 2016$761,000
-64.6%
25,919
-5.6%
0.00%
-62.5%
Q4 2015$2,152,000
+12.1%
27,449
+7.8%
0.01%
+14.3%
Q3 2015$1,919,000
-33.0%
25,466
+3.8%
0.01%
-30.0%
Q2 2015$2,863,000
-30.0%
24,526
+41.5%
0.01%
-28.6%
Q1 2015$4,091,000
+18.0%
17,327
-5.4%
0.01%
+27.3%
Q4 2014$3,467,000
-20.5%
18,318
+0.2%
0.01%
-21.4%
Q3 2014$4,361,000
+256.0%
18,279
-1.5%
0.01%
+250.0%
Q2 2014$1,225,000
-19.5%
18,559
+27.0%
0.00%
-20.0%
Q1 2014$1,522,000
+19.7%
14,617
+19.0%
0.01%
+25.0%
Q4 2013$1,272,000
+93.0%
12,2870.0%0.00%
+100.0%
Q3 2013$659,000
+22.5%
12,287
+1.4%
0.00%0.0%
Q2 2013$538,00012,1170.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders